Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
10
pubmed:dateCreated
1986-2-14
pubmed:abstractText
Two new murine monoclonal IgG1 antibodies, H-31 and H-A26, were characterized in comparison with two previously obtained monoclonal antibodies against human interleukin 2 (IL-2) receptor (IL-2 R), anti-Tac and HIEI. In immunofluorescence assays with various human hematopoietic cells, H-31 and H-A26 antibodies both reacted with only IL-2 R-positive cells, and they precipitated IL-2 R molecules, glycoproteins with molecular weights of 60K and 53K daltons (gp60/gp53), from human T-cell leukemia virus type I (HTLV-I)-carrying MT-2 cells, as demonstrated by sequential immunoprecipitation after absorption of IL-2 R with anti-Tac. Antibody-binding competition assays showed that H-31 and anti-Tac, and H-A26 and HIEI, respectively, competed reciprocally in binding to the cells, and that anti-Tac also inhibited the binding of HIEI but not vice versa. H-31, like anti-Tac, strongly inhibited the IL-2-dependent proliferation of normal activated T-cells, absorption of IL-2 and direct binding of IL-2 to the cells, while H-A26, like HIEI, inhibited those processes only weakly. The spectra of reactivities of these antibodies with various simian cell lines derived by HTLV-I infection were different, as revealed by immunofluorescence studies. Human IL-2 R was shown to express a unique antigenic determinant, detected with HIEI, that was not detectable in IL-2 R molecules of Old and New World monkeys, and also to express determinants common to simian IL-2 R molecules. These observations indicate that H-31 and H-A26 recognize human IL-2 R molecules and that the antigenic sites on the IL-2 R molecule defined by H-31, H-A26, anti-Tac, and HIEI are different.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
0385-5600
pubmed:author
pubmed:issnType
Print
pubmed:volume
29
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
959-72
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:2417094-Animals, pubmed-meshheading:2417094-Antibodies, Monoclonal, pubmed-meshheading:2417094-Antibody Specificity, pubmed-meshheading:2417094-Antigens, CD27, pubmed-meshheading:2417094-Antigens, Surface, pubmed-meshheading:2417094-Binding, Competitive, pubmed-meshheading:2417094-Cell Transformation, Viral, pubmed-meshheading:2417094-Deltaretrovirus, pubmed-meshheading:2417094-Epitopes, pubmed-meshheading:2417094-Haplorhini, pubmed-meshheading:2417094-Humans, pubmed-meshheading:2417094-Lymphocyte Activation, pubmed-meshheading:2417094-Mice, pubmed-meshheading:2417094-Phytohemagglutinins, pubmed-meshheading:2417094-Receptors, Immunologic, pubmed-meshheading:2417094-Receptors, Interleukin-2, pubmed-meshheading:2417094-Species Specificity, pubmed-meshheading:2417094-T-Lymphocytes
pubmed:year
1985
pubmed:articleTitle
Distinct reactivities of four monoclonal antibodies with human interleukin 2 receptor.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't